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ABSTRACT
Background: Sweetpotato and potato are fast-maturing staple crops and widely consumed in low- and middle-income
countries. Conventional breeding to biofortify these crops with iron could improve iron intakes. To our knowledge, iron
absorption from sweetpotato and potato has not been assessed.
Objective: The aim was to assess iron absorption from regular and iron-biofortified orange-fleshed sweetpotato in
Malawi and yellow-fleshed potato and iron-biofortified purple-fleshed potato in Peru.
Methods: We conducted 2 randomized, multiple-meal studies in generally healthy, iron-depleted women of
reproductive age. Malawian women (n = 24) received 400 g regular or biofortified sweetpotato test meals and Peruvian
women (n = 35) received 500 g regular or biofortified potato test meals. Women consumed the meals at breakfast
for 2 wk and were then crossed over to the other variety. We labeled the test meals with 57Fe or 58Fe and measured
cumulative erythrocyte incorporation of the labels 14 d after completion of each test-meal sequence to calculate iron
absorption. Iron absorption was compared by paired-sample t tests.
Results: The regular and biofortified orange-fleshed sweetpotato test meals contained 0.55 and 0.97 mg Fe/100 g.
Geometric mean (95% CI) fractional iron absorption (FIA) was 5.82% (3.79%, 8.95%) and 6.02% (4.51%, 8.05%),
respectively (P = 0.81), resulting in 1.9-fold higher total iron absorption (TIA) from biofortified sweetpotato (P < 0.001).
The regular and biofortified potato test meals contained 0.33 and 0.69 mg Fe/100 g. FIA was 28.4% (23.5%, 34.2%)
from the regular yellow-fleshed and 13.3% (10.6%, 16.6%) from the biofortified purple-fleshed potato meals, respectively
(P < 0.001), resulting in no significant difference in TIA (P = 0.88).
Conclusions: FIA from regular yellow-fleshed potato was remarkably high, at 28%. Iron absorbed from both potato
test meals covered 33% of the daily absorbed iron requirement for women of reproductive age, while the biofortified
orange-fleshed sweetpotato test meal covered 18% of this requirement. High polyphenol concentrations were likely the
major inhibitors of iron absorption. These trials were registered at www.clinicaltrials.gov as NCT03840031 (Malawi) and
NCT04216030 (Peru). J Nutr 2020;00:1–9.
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Introduction
Iron deficiency anemia (IDA) is a major cause of the global
burden of disease in women (1). It causes fatigue and reduces
physical performance, and during pregnancy increases the risk
of preterm birth and low birth weight (2, 3). In low- and middle-
income countries (LMICs), a common cause of iron deficiency
(ID)/IDA is insufficient intake of bioavailable iron from
monotonous plant-based diets (4). The estimated prevalence of
ID in women of reproductive age is 15.1% in Malawi (5), while
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anemia prevalence in this population group is 21.1% in Peru
(6). A common strategy to combat ID is iron supplementation,
but compliance with iron supplementation is often low, and high
iron doses may increase infection risk and cause gut dysbiosis
and inflammation (7). Thus, alternative approaches to increase
iron intakes in women in LMICs are needed (8).
Biofortification, the process by which the micronutrient
quantity of food crops is enhanced through conventional plant
breeding or biotechnology, is a promising approach to increase
iron content in staple food crops (9). Efficacy trials of iron-
biofortified beans and pearl millet have shown these crops can
improve iron status, increasing serum ferritin and total body
iron (10, 11).
Sweetpotato breeding efforts during the past decade in
sub-Saharan Africa have focused on developing vitamin
A–rich, orange-fleshed sweetpotato varieties to address the
high prevalence of vitamin A deficiency (48%) among young
children (12). Sweetpotato was one of the most harvested
food crops in Malawi in 2018 (13, 14) and orange-fleshed
types make up a significant percentage of total sweetpotato
production. Potato is the third most harvested food crop in the
world and Peru is the biggest producer in Latin America (13),
with Peruvian women consuming up to 800 g of potato daily
(15). In Malawi, data on sweetpotato consumption in women
are not available, but >60% of children consumed any type of
sweetpotato at least once a week (16) and 100 g of available
orange-fleshed varieties meets the daily vitamin A needs of
young children (12). Thus, these countries are potential targets
for iron biofortification of these crops. For both crops, there
has been considerable progress in increasing their iron content
through conventional breeding (17–19).
Iron absorption from potato and sweetpotato is predicted
to be high due to the relatively low phytate and high ascorbic
acid content in comparison to cereals (20–23). In vitro iron
bioaccessibility (amount of iron released from the food matrix
during in vitro gastrointestinal digestion and available for
absorption at the intestinal level) was 63–79% in potato (24)
and 47–62% in sweetpotato (21) compared with 6–24% in
pearl millet, different types of beans, and rice (25).
The aims of our study were to assess iron bioavailability from
test meals prepared with 1) regular (a released orange-fleshed
variety) and iron-biofortified orange-fleshed sweetpotato (a
clone from the on-going breeding program for high iron) in
Malawian women and 2) from regular yellow-fleshed potato
(a commercial popular landrace) and iron-biofortified purple-
fleshed potato (a clone from the on-going breeding program for
high iron) in Peruvian women. In both studies, we assessed iron
bioavailability by measuring iron stable isotope incorporation
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into erythrocytes after consumption of multiple labeled test
meals (11, 26).
Methods
Study site and subjects
The sweetpotato study was conducted from March to April 2019 in the
Zomba area (altitude, 949 m) of southern Malawi. The potato study was
conducted from May to August 2019 in the department of Huancavelica
(altitude, 3600 m) in the central highlands of Peru.
Both studies used a 2-stage screening approach (Figure 1). In
Malawi, we recruited women in communities surrounding Zomba
Central Hospital. In Peru, we recruited women at the National
University and the Instituto Pedagógico of Huancavelica. We first
prescreened interested women for the inclusion criteria of age (self-
reported) and weight (measured in both studies using a SECA scale;
model 813; SECA). Women who met these inclusion criteria were then
invited for full screening. The inclusion criteria for both studies were
as follows: body weight (<65 kg), BMI (kg/m2; 18.5–25.0), age 18–
35 y (Malawi) and 18–25 y (Peru), serum ferritin (SF; Malawi) or
plasma ferritin (PF; Peru) concentration ≤25 μg/L, C-reactive protein
(CRP) concentration <5 mg/L and hemoglobin (Hb) >80 g/L [adjusted
for altitude (27) in Peru], not pregnant (assessed by using a urine
pregnancy test) or lactating, no chronic diseases or medications that
could influence iron metabolism, no current intake of mineral and/or
vitamin supplements or willing to discontinue supplementation 2 wk
prior to study start, no current participation in any clinical trial or
during the past month prior to study start, able to comply with all
study procedures, and no presence of fever (>37.5◦C) on the first study
day. For Malawi, additional exclusion criteria were: having taken an
iron supplement in the last 3 mo, enrollment in any supplemental food
program, and self-reported alcohol consumption of >2 drinks/d.
Ethical issues
The sweetpotato study in Malawi was approved by the Ethics
Commission of ETH Zürich, Switzerland, and by the College of
Medicine Research and Ethics Committee, Malawi. The potato study in
Peru was approved by the Comité de Ética en Investigación of Instituto
de Investigación Nutricional and received written permission without
full review from the Ethics Commission of ETH Zürich. In both studies,
participants gave written informed consent. The studies were registered
under Clinical Trial Identifier numbers NCT03840031 (Malawi) and
NCT04216030 (Peru).
Intervention
In Malawi, we invited the 30 women with the lowest SF results
at screening, and who met all the other inclusion criteria, for a
test feeding day. On this day, we fed the women a standardized
test meal consisting of 400 g mashed orange-fleshed sweetpotato
(regular or iron-biofortified). After finishing the test meal, women
remained fasting for 3 h. Information on sociodemographic status
was collected via a standardized electronic questionnaire using the
REDCap® platform (Vanderbilt) (28). At the end of the 3-h post–test
meal period, we administered a single 400-mg dose of albendazole and
the first dose of malaria prophylaxis (the dose was 3 tablets for study
participants <60 kg or 4 tablets for study participants ≥60 kg; each
tablet contained 40 mg dihydroartemisinin and 320 mg piperaquine).
Women were instructed to take the next 2 doses after lunch the next
day and the day after. One woman experienced a mild adverse drug
reaction and was excluded. Four women did not show up on the test
feeding day. Therefore, 25 women started the iron absorption study 3
d after the test feeding day. In Peru, we did not have a test feeding day,
and all women began the absorption study 1 wk after screening. We
used a blockwise inclusion of a maximum of 10 women/wk until 39
women were enrolled, which was reached after 8 wk. In both studies,
we used a nonblinded, randomized, crossover, multiple-meal design
to measure fractional iron absorption (FIA) and total iron absorption
(TIA) from 1) regular and iron-biofortified orange-fleshed sweetpotato
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FIGURE 1 Study overview diagrams for the sweetpotato study in Malawi and the potato study in Peru. CRP, C-reactive protein; Hb, hemoglobin;
PF, plasma ferritin; SF, serum ferritin.
meals in Malawi and 2) regular yellow-fleshed and iron-biofortified
purple-fleshed potato meals in Peru (Figure 2).
In both studies on the first study day, we collected a venous blood
sample to determine baseline isotopic composition as well as iron
and inflammation status markers. Women began consuming the first
randomly assigned test meal type labeled with the corresponding iron
isotope (in Malawi: 0.33 mg 57Fe or 58Fe for the regular and biofortified
sweetpotato; in Peru: 0.5 mg 57Fe or 58Fe for the regular and biofortified
potato) (Figure 2). The assigned test meal was consumed as breakfast
for 10 consecutive days, interrupted by a weekend break. On day 15,
all participants switched over to the second test meal type, which they
consumed for another 10 d. Each test meal was weighed before and after
consumption to calculate the exact intrinsic iron intake. Meals were
consumed under direct supervision by the study team after overnight
fasting was confirmed. We observed the women for 3 h after the test
meals and no food or drink was allowed other than mineral water
(500 mL). On day 15 (Peru only), 26, and 40, trained staff collected
venous blood to measure iron and inflammation markers, and isotopic
composition was measured in the day 26 and 40 samples. In Malawi,
a medical doctor assessed participants who tested positive for malaria
or who presented with other health problems and decided on further
treatment. In Peru, subjects developing a fever or other symptoms of
illness were discontinued from the study and advised to consult their
medical doctor.
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FIGURE 2 Study design for the sweetpotato study in Malawi (M) and the potato study in Peru (P). In both studies women were randomly
assigned to either the regular OFSP (M), YFP (P), or iron-biofortified OFSP (M), PFP (P) test meals with iron isotopic administration (regular test
meal, 57Fe, or iron-biofortified test meal, 58Fe) for 10 consecutive days, after which they crossed over to the other test meal sequence. OFSP,
orange-fleshed sweetpotato; PFP, purple-fleshed potato; Sobo® (Southern Bottlers Ltd); YFP, yellow-fleshed potato.
Test meal preparation and composition
In Malawi, the test meals consisted of a standardized recipe including
400 g of steamed and mashed orange-fleshed sweetpotato (details of
meal preparation are provided in the Supplemental Material) of either
the released variety Irene (regular, 7.7 ppm Fe in raw roots) or the
breeding clone MUSG15052-2 (high-iron, 15.8 ppm Fe in raw roots).
Both sweetpotato varieties were bred, grown, and harvested by the
International Potato Center (CIP) in Mozambique in collaboration with
the Instituto de Investigação Agrária de Mozambique. We served 250
mL diluted Sobo® Squash Orange (Southern Bottlers Ltd; 1:4 dilution
using bottled water) with every test meal, and an additional 50 mL
was used for isotope administration after half of the test meal was
consumed.
In Peru, the test meals consisted of a standardized meal of 500 g
of boiled and mashed potato (details of meal preparation are provided
in the Supplemental Material) of either the released variety Peruanita
(regular yellow-fleshed potato, 3.0 ppm Fe in raw tubers) or the breeding
clone CIP306417.79 (high-iron purple-fleshed potato, 5.6 ppm Fe in
raw tubers). The regular yellow-fleshed variety was purchased from a
local farmer in Paucartambo, while the iron-biofortified purple-fleshed
clone was grown and harvested by CIP in the same locality. Each
participant received 200 mL of mineral water with every test meal and
an additional 50 mL was used for isotope administration after half of
the test meal was consumed.
Stable isotope labels
57FeSO4 and 58FeSO4 were prepared from 57Fe-enriched elemental iron
(95.6% isotopic enrichment) and 58Fe-enriched elemental iron (99.9%
isotopic enrichment; all Chemgas, Boulogne, France) by dissolution in
0.1 M sulfuric acid. Individual 5-mL doses [containing 3.3 mg (Malawi)
and 5.0 mg (Peru) of labeled iron], sufficient to label the 10 test meals
for each participant and meal type were prepared. These were stored
in 5-mL Teflon vials and flushed with argon to keep the iron in the
+II oxidation state. All labeled iron compounds were analyzed for iron
isotopic composition and iron concentration by inductively coupled
plasma (ICP)–MS (Neptune; Thermo-Fisher Scientific).
Test meal analyses
We analyzed the nutrient composition of both fresh uncooked varieties
of sweetpotato/potato as well as their test meals. Iron and calcium
concentrations were determined by ICP–MS (iCAP; Thermo-Fisher
Scientific) after mineralization using HNO3 by microwave digestion
(MLS TurboWave; MLS GmbH). Phytic acid (PA) concentration
was measured using a modification of the Makower method (29),
as described previously by our laboratory (30). We measured total
polyphenol (PP) concentration using a modified Folin-Ciocalteau
method (31, 32), and expressed the results as Gallic acid equivalents
(GAEs). For all Malawi samples, ascorbic acid (AA) was analyzed after
stabilization and extraction in meta-phosphoric acid and reduction via
dithiothreitol with HPLC (Acquity H-class UPLC system, 4824949;
Waters AG). The Peru samples were analyzed for AA by UV/Visible
spectroscopy (UV 160A; Shimadzu Corp), as described by Burgos et
al. (33).
Blood collection and analysis
In Malawi, Hb and CRP concentrations were measured using a
QuikRead device (QuikRead go CRP+Hb; Orion Diagnostica) and
the presence of Plasmodiumfalciparum malaria antigen using a rapid
immunochromatographic test (Parahit® f ver 1.0; M/S Span Diagnostics
Inc). One serum aliquot from each screened participant was sent
to Blantyre, Malawi, for SF analyses at the Blantyre Diagnostics
Laboratory using a manual ELISA microplate immunoenzymometric
assay (BXE0891A; Biorex Diagnostics). In Peru, Hb was measured in
whole blood using a 5-differential flow cytometer (Nihon Kohden),
PF by electrochemiluminescence (Cobas E 411; Roche Diagnostics),
and CRP by turbidimetry (Vitros 4600; Ortho Clinical Diagnostics). In
Malawi, the presence of P. falciparum malaria antigen as described for
the screening and Hb concentration using a hematology analyzer (Xp-
300; Sysmex Suisse AG) were assessed at all blood collection points
during the feeding days to check participants’ health status. In Peru, Hb
was measured in whole blood as described for the screening samples at
all blood collection points during the feeding days.
All aliquoted samples collected during the absorption studies were
stored frozen at −18◦C and shipped on dry ice from both study sites to
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TABLE 1 Composition of the test meals provided to women in Malawi and Peru1










Variety name Irene Clone MUSG-15052-2 Peruanita Clone 306417.79
Iron, native, mg/100 g 0.55 ± 0.03 0.97 ± 0.07 0.33 ± 0.03 0.69 ± 0.07
AA, mg/100 g 7.4 ± 0.1 1.1 ± 0.2 8.8 ± 2.5 12.7 ± 1.3
AA:iron, molar ratio 3.7 0.3 6.5 5.1
PA, mg/100 g <LOQ2 <LOQ2 4.8 ± 0.9 31.7 ± 5.1
PA:iron, molar ratio — — 1.0 3.4
Total polyphenols, mg GAE/100 g 45.8 ± 3.9 57.4 ± 2.8 29.6 ± 2.3 105.6 ± 7.9
Calcium, mg/100g 26.3 ± 0.3 40.3 ± 0.6 5.4 ± 0.6 7.3 ± 0.5
1Values are means ± SDs unless otherwise indicated. AA, ascorbic acid; GAE, gallic acid equivalents; LOQ, limit of quantification; PA, phytic acid.
2Below the LOQ of 12 mg/100 g dry matter.
the Human Nutrition Laboratory of ETH Zürich. Analyses of ferritin,
soluble transferrin receptor (sTfR), CRP, and α1-acid glycoprotein
(AGP) were done using immunoassay (34). Whole-blood samples
were analyzed in duplicate for their iron isotopic composition after
mineralization by microwave digestion (MLS TurboWave; MLS GmbH)
followed by iron separation from the blood matrix by anion-exchange
chromatography and a subsequent purification step by precipitation as
iron hydroxide using ICP-MS (Neptune; Thermo-Fisher Scientific) (35).
Calculation of iron absorption
We calculated the amounts of 57Fe and 58Fe isotopic labels in RBCs 14 d
after each meal sequence on the basis of the shift in iron-isotope ratios
and the estimated amount of iron circulating in the body. Circulating
iron was calculated based on blood volume estimated from height
and weight and mean Hb concentration at days 1 and 40 (36). The
calculations were based on the principles of isotope dilution (37). For
calculation of fractional absorption, it was assumed that 80% of the
absorbed iron was incorporated into RBCs (38).
Sample size calculation
Both studies assumed an SD of 0.18 on log-transformed FIA from a
previous study using iron-biofortified millet in nonpregnant Beninese
women (11). With the type I error rate set to 5% we had 90% power to
detect a 35% difference in TIA (regular vs. iron-biofortified test meal)
with a sample size of 20 participants. To account for potential dropouts,
which were anticipated to be higher in Peru, we enrolled 25 women in
Malawi and 39 women in Peru.
Statistical analysis
We performed statistical analyses using STATA (version 15.0; StataCorp
LLC) and Excel (version 2018; Microsoft). Normally distributed data
tested by Shapiro-Wilk were reported as means (±SDs) or geometric
means (±SDs) if normally distributed after log transformation. Non–
normally distributed data after log transformation were reported as
medians (IQRs). To compare FIA within participants from the 2 test
meals (regular vs. iron-biofortified), we used paired t test. In order
to assess within-subject variation in iron status and inflammation on
measured time points, ANOVA or Wilcoxon signed-rank test was
performed. P values <0.05 were considered statistically significant.
Results
In Malawi, 1 woman had to be excluded from the study due to
an elevated CRP concentration (>5 mg/L) and the presence of
fever on day 1 (Figure 1). Two women were treated during the
test meal feedings with antibiotics and 1 woman was treated for
malaria on the final study day. In Peru, 2 women were excluded
on day 1 (1 woman with a CRP concentration >5 mg/L, 1
woman not able to consume the whole test meal) and 2 women
dropped out due to illness during the feeding period (Figure 1).
The composition of the sweetpotato and potato test
meals is summarized in Table 1. In Malawi, the average
daily consumption (±SD) of the regular and iron-biofortified
orange-fleshed sweetpotato meals was 433 ± 5 g and 444 ± 5
g, respectively, resulting in a daily intrinsic iron intake of 2.38
(± 0.03) mg from the regular test meal and 4.32 (± 0.04) from
the iron-biofortified test meal. PA concentrations were low in
both test meals, while AA content was low (1.1 ± 0.2 mg/100
g) in the biofortified meal and moderate (7.4 ± 0.2 mg/100 g) in
the regular meal. PP content, expressed as GAEs, was high, with
198 and 255 mg PP in the total regular and biofortified meals,
respectively. Sobo® (Southern Bottlers Ltd), which was used to
administer the isotopes in Malawi, contributed only 0.48 mg
AA per meal serving. In Peru, the average daily consumption
(±SD) of the regular and iron-biofortified potato meals was
500 ± 1 g and 500 ± 0.5 g, respectively, resulting in a daily
intrinsic iron intake of 1.63 ± 0.02 mg from the regular yellow-
fleshed potato meal and 3.47 ± 0.05 mg from the biofortified
purple-fleshed potato meal. Both test meals contained some PA
and AA and high concentrations of PP, being 3.5-fold higher in
the biofortified purple-fleshed meal compared with the regular
yellow-fleshed meal (528 and 148 mg GAEs, respectively).
Baseline characteristics for the Malawian and Peruvian
women are shown in Table 2. In Malawi, 5 women (20.8%)
were ID (PF ≤12 μg/L) and 4 of these women had IDA; an
additional 5 women were anemic without ID. In Malawi, due
to a technical error in the serum ferritin measurements during
TABLE 2 Baseline (day 1) characteristics of women who
consumed the test meals and were included for final data





Age, y 24.9 ± 4.81 21.4 ± 2.0
Weight, kg 54.7 ± 4.44 51.9 ± 6.4
BMI, kg/m2 21.8 ± 2.0 22.5 ± 1.9
Hemoglobin, g/L 123.1 ± 11.2 122.5 ± 9.32
Plasma ferritin, μg/L 21.4 [15.0, 30.5] 9.6 [7.6, 12.3]
Soluble transferrin receptor, mg/L 6.4 (5.5–7.7) 5.7 (5.1–7.3)
C-reactive protein, mg/L 0.53 [0.35, 0.82] 0.11 [0.07, 0.20]
α1-Acid glycoprotein, g/L 0.58 (0.43–0.66) 0.42 (0.36–0.51)
1Values are means ± SDs, geometric means [95% CI], or medians (IQR).
2Hemoglobin values for Peru were corrected for altitude (27).
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FIGURE 3 Fractional iron absorption (%) (A, C) and total iron absorption (mg/d) (B, D) from regular and iron-biofortified OFSP test meals
in Malawian women (A, B; n = 24) and from regular YFP and iron-biofortified PFP test meals in Peruvian women (C, D; n = 35). Isotopic
administration in both studies: 57Fe for the regular test meal and 58Fe for the iron-biofortified test meal. The horizontal lines represent geometric
means (95% CIs). OFSP, orange-fleshed sweetpotato; PFP, purple-fleshed potato; YFP, yellow-fleshed potato.
screening, only 14 of the 24 women had a PF ≤25 μg/L at
baseline (PF range: 2.69–115.40 μg/L). In Peru, 31 of the 34
women had a PF ≤25 μg/L at baseline, 22 were ID (64.7%)
and 12 of these women were IDA, while 2 women were anemic
without ID. Iron and inflammation status markers did not
significantly change over the 6-wk study period in both studies.
In Malawi, FIA (geometric mean; 95% CI) did not differ
(P = 0.81) between the regular (5.82; 3.79, 8.95) and
iron-biofortified sweetpotato test meals (6.02; 4.51, 8.05)
(Figure 3). TIA in milligrams per day (geometric mean;
95% CI) was significantly higher (P < 0.001) from the
biofortified test meal (0.26; 0.19, 0.35) compared with the
regular test meal (0.14; 0.09, 0.21), resulting in a 1.9-fold
higher amount of iron absorbed daily and covering 18% of
the median daily requirement for absorbed iron in women
of reproductive age (39). The geometric mean (95% CI) FIA
from the iron-biofortified orange-fleshed sweetpotato test meal
for participants with PF >25 μg/L (n = 10) was 3.98 (2.49,
6.39) but was 8.09 (5.87, 11.15) for participants with PF
≤25 μg/L (n = 14), demonstrating the well-known influence
of iron status on FIA. Thus, women with low iron stores
would obtain 25% of their daily needs for absorbed iron when
consuming the biofortified orange-fleshed sweetpotato test
meal.
In Peru, FIA (geometric mean; 95% CI) was significantly
higher (P < 0.001) from the regular yellow-fleshed potato
meal (28.4; 23.5, 34.2) compared with the iron-biofortified
purple-fleshed test meal (13.3; 10.6, 16.6) (Figure 3). TIA in
milligrams per day (geometric mean; 95% CI), however, was
not different (P = 0.88) between the regular (0.46; 0.38, 0.56)
and biofortified (0.46; 0.37, 0.57) test meal providing 33% of
the median daily iron requirement for absorbed iron in women
of reproductive age (39).
Discussion
In Malawi, women absorbed 0.26 mg Fe/d from iron-
biofortified orange-fleshed sweetpotato, 0.12 mg more than
from regular meals, while FIA did not differ (6%). In contrast,
in Peru, the FIA from iron-biofortified purple-fleshed potato
(13.3%) was half that from the regular yellow-fleshed variety
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(28.4%), resulting in the same daily quantity of iron absorbed
(0.46 mg). The FIA of both the regular yellow-fleshed and
biofortified purple-fleshed potato was above the expected
5–10% for plant-based diets in LMICs (40) when consumed as a
single-food test meal. These iron absorption estimates, however,
are based on a mixed diet high in PA, the main inhibitor of
nonheme iron absorption (41). The inhibitory PA:Fe molar
ratio >1 for iron absorption from legume-based meals was
only exceeded in the potato test meals; therefore, it is unlikely
to have contributed to the low FIA from the orange-fleshed
sweetpotato test meals (42). In biofortified beans, the removal of
PA only slightly increased iron absorption, suggesting a stronger
inhibitory effect of polyphenols (43, 44).
All sweetpotato and potato test meals contained significant
amounts of PP (expressed in GAEs), with the biofortified purple-
fleshed potato meal containing 3-fold more PP (528 mg) than
the regular yellow-fleshed test meal (148 mg) and about twice
that of the regular (198 mg) and biofortified (255 mg) orange-
fleshed sweetpotato test meals. For sweetpotato, but not potato,
PP values are considerably higher than previously reported
values of 5–21 mg PP GAEs per 100 g raw orange-fleshed
sweetpotato roots (21, 45). The considerably lower FIA from
the biofortified purple-fleshed potato test meal is likely to be
related to its higher PP content, linked to its purple-fleshed color,
compared with the yellow-fleshed color of the regular variety,
as shown elsewhere (23). In a series of human iron absorption
studies using bean hulls as the source of PP, FIA from a low
inhibitory test meal decreased by 45% when 200 mg PP was
added (46). Similarly, FIA was reduced from 10.7% to 2.7%
at PP GAE amounts of 17 mg and 167 mg, respectively, in
iron-biofortified pearl millet test meals (47). Phenolic acids in
sweetpotato and potato consist of a mixture that is highest in
chlorogenic acids (hydroxycinnamic acid derivatives) followed
by rutin (flavonol), caffeic acid (caffeoylquinic acid derivatives),
and in purple-fleshed potatoes, anthocyanins (23, 48). In in vitro
digestions with boiled sweetpotato and potato, bioaccessible
chlorogenic acid was released after gastric and intestinal
digestion, which might chelate iron during digestion making
it unavailable for absorption (49). Although PPs may impair
iron absorption, they also have positive health effects including
their antioxidant properties (23, 48, 50). On the other hand,
β-carotene in orange-fleshed sweetpotato might prevent the
chelating effect of phytate and phenolic acids on iron, improving
its absorption (51, 52). Since we did not analyze β-carotene in
the orange-fleshed sweetpotato test meals, the potential effect
remains unclear.
The AA concentration was low in the biofortified sweet-
potato test meal, but in both potato test meals and in the
regular sweetpotato test meal the molar ratio of AA:Fe was
>1, the threshold for enhancing iron absorption (21, 53). AA is
sensitive to food processing and meal preparation. Microwave
heating decreased AA content in potatoes by 61–94% (54),
and freezing for >5 wk resulted in losses of 23% (55). We
found that 54% and 46% of AA was lost in the steamed,
frozen, and microwaved regular and biofortified sweetpotato
test meals, respectively. In Peru, we found that 17% and 14% of
AA was lost during boiling and mashing. In addition, while AA
content in the biofortified test meals was stable during storage,
AA concentration in the regular potato test meals decreased by
>50% during the study.
Calcium content of the regular and biofortified sweetpotato
test meals was 114 and 179 mg, respectively, which includes
the added calcium through milk (∼34 mg). In contrast, calcium
content was only 26 and 37 mg in the regular and biofortified
potato test meals. Calcium is a dose-dependent iron inhibitor
at amounts >50 mg in a meal (56–58) and the higher calcium
content in the sweetpotato meals may have contributed to the
lower FIA from those meals. Human intestinal Caco-2 cells
exposed to high calcium concentrations show different gene-
expression patterns and localization sites for the divalent metal
transporter 1 (DMT1) and ferroportin over time, suggesting
a possible influence of dietary calcium on key transporters
involved in iron absorption (59, 60).
Iron status and inflammation also influence iron absorption
(42, 61) through modulation of circulating hepcidin (62). In
Peru, 86% of the women had PF ≤25 μg/L and the geometric
mean (95% CI) PF concentration was lower (9.7; 7.6, 12.3
μg/L) than in Malawi (21.4; 15.0, 30.5 μg/L), where 58% of the
women had SF ≤25 μg/L. Thus, poorer iron status in Peru likely
contributed to higher iron absorption compared with Malawi.
In contrast, inflammation was similarly low in both settings and
is therefore unlikely to have affected iron absorption (63).
Another factor that probably affects iron absorption in Peru
is altitude. The Peruvian study population lives in Huancavelica
at 3600 m above sea level. In a Bolivian study looking at the
effect of living at high altitude, lower body iron measurements
were found despite normal Hb values corrected for altitude,
suggesting that the women were able to enhance dietary iron
absorption to acquire the additional iron needed for RBC mass
expansion (64). These findings are in accordance with current
studies, which suggest that hypoxia-inducible factor 2 (HIF-2)
mechanisms increase intestinal iron absorption by upregulating
erythropoietin (EPO) and DMT1 activation and suppressing
hepcidin when iron deficiency or increased erythropoiesis occurs
(65). High-altitude populations in Tibet show modification of
HIF-2–associated genes (66). The influence of high altitude on
FIA needs to be investigated in follow-up studies.
Meals based only on potatoes are very common in the
Andean highlands. Such a meal containing 500 g of either
regular yellow-fleshed or biofortified purple-fleshed potatoes
would make a substantial contribution to iron nutrition by
providing 33% of the daily requirement for absorbed iron in
women of reproductive age (39).
Since de Haan et al. (15) found daily potato intakes of up to
800 g in the region, the daily iron contribution of potato could
be even higher. Further, conventionally bred iron-biofortified
yellow-fleshed potato varieties currently developed by the CIP
are expected to have a higher FIA, because of the yellow variety’s
lower PP content compared with the biofortified purple-fleshed
variety tested in this study, and studies are planned to test
these varieties. In contrast, due to lower iron absorption from
the orange-fleshed sweetpotato test meals, the contribution to
daily iron requirements in women would be 10% from the
regular compared with 18% from the biofortified sweetpotato.
However, this contribution from the biofortified sweetpotato
might increase to 25% when consumed by women with low
iron stores (SF ≤25 μg/L). Since habitual consumption data of
sweetpotato are not available from Malawi, its contribution
to daily iron intake is difficult to estimate. Considering that
sweetpotato would likely be consumed in combination with
other foods that contain iron enhancers and inhibitors, the daily
iron contribution may vary. Several approaches could increase
iron absorption from sweetpotato in a mixed Malawian diet,
as follows: 1) sweetpotato AA concentration could be increased
by breeding, 2) preparation methods could be used that do not
degrade AA, 3) AA could be added additionally to the sweet-
potato meal (67), and/or 4) food-to-food fortification could be
achieved by adding AA-rich fruits to sweetpotato meals.
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To conclude, both of the tested varieties of iron-biofortified
sweetpotato and potato could potentially contribute to
improved iron intakes and absorption, but breeding for varieties
with higher iron, AA, and lower PP concentrations to increase
iron bioavailability should be a focus of future research. In
addition, iron absorption from biofortified sweetpotatoes and
potatoes should be evaluated as a component of a mixed diet in
other settings in Africa and Asia. Also, the high iron absorption
from potato should be confirmed in populations living at lower
altitudes.
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